Planning for the invisible: Projecting resources needed to identify and treat all patients with MDR-TB

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 4, 2013, Pages 427-428

  Mitnick, Carole D ^a,b,c   Keravec, Joel ^d,e   Cohen, Ted ^c,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PARTNERS IN HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Stop TB Partnership   (Switzerland)

^e Management Sciences for Health ^*  (Brazil)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; EDITORIAL; HEALTH CARE NEED; HEALTH CARE PLANNING; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; PATHOGEN LOAD; PRIORITY JOURNAL; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84875468490     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0110     Document Type: Editorial

References (9)

1. Royce S, Falzon D, van Weezenbeek C, et al. Multidrug resistance in new tuberculosis patients: burden and implications. Int J Tuberc Lung Dis 2013; 17: 511-51-3.
2. World Health Organization. Multidrug and extensively drugr esistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 201-0.
3. World Health Organization. Global tuberculosis report 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 201-2.
4. World Health Organization. TB impact measurement: policy and recommendations for how to assess the epidemiological burden of TB and the impact of TB control. Stop TB policy paper no 2. WHO/HTM/TB/2009.416. Geneva, Switzerland: WHO, 200-9.
5. Lönnroth K, Corbett E, Golub J, et al. Systematic screening for active tuberculosis: rationale, definitions and key considerations [State of the art series. Active case finding/screening. Number 1 in the series]. Int J Tuberc Lung Dis 2013; 17: 289-29-8.
6. Dierberg K, Dorjee K, Cronin W, et al. Improved tuberculosis case-finding and MDR-TB detection among Tibetan refugees in India. 43rd World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease, 13-17 November 2012, Kuala Lumpur, Malaysia. Int J Tuberc Lung Dis 2012; 16 (Suppl 1): S221. [Abstract]
7. Hausler H, Skiti V, McLoughlin J, et al. Using community resources and new tools for active tuberculosis case detection in South Africa. 43rd World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease, 13-17 November 2012, Kuala Lumpur, Malaysia. Int J Tuberc Lung Dis 2012; 16 (Suppl 1): S2. [Abstract]
8. Steingart K R, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013; 1: CD00959-3.
9. Grosset J H, Singer T G, Bishai W R. New drugs for the treatment of tuberculosis: hope and reality. Int J Tuberc Lung Dis 2012; 16: 1005-101-4.